Aldosterone esters and the heart

American Journal of Hypertension

Volumn 14, Issue 6 II, 2001, Pages

  Gomez Sanchez, Celso E ^a   Foecking, Mark F ^b   Gomez Sanchez, Elise P ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b University of Missouri   (United States)

Author keywords

Aldosterone; Aldosterone acetate; Cardiac fibrosis

Indexed keywords

ALDOSTERONE DERIVATIVE;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROLYTE BALANCE; FLUID BALANCE; HEART; HEART MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; THIN LAYER CHROMATOGRAPHY;

EID: 0034994299     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(01)02089-1     Document Type: Conference Paper

References (54)

1. The steroid and thyroid hormone receptor superfamily
2. Nongenomic actions of steroid hormones
3. Mineralocorticoid binding in cultured smooth muscle cells and fibroblasts from rat aorta
4. Mineralocorticoid receptor in rat kidney and hippocampus: Characterization and quantitation by isoelectric focusing
5. Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart
6. Steroid binding to cardiac type I receptors: In vivo studies
7. High affinity aldosterone binding sites (type I receptors) in rat heart
8. Aldosterone action: Fact, failure and the future
9. Mineralocorticoid receptor antagonist protects stroke-prone hypertensive rats against vascular injury
10. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma
11. Left ventricular systolic function in primary aldosteronism and hypertension
12. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension
13. Mineralocorticoid excess, dietary sodium and myocardial fibrosis
14. Mineralocorticoids, salt, hypertension: Effects on the heart
15. Aldosterone and the heart
16. Three forms of rat CYP11B genes: 11β-hydroxylase gene, aldosterone synthase gene, and a novel gene
17. Expression of cytochromes P450aldo and P45011β in rat adrenal gland during late gestational and neonatal stages
18. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells
19. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin
20. Aldosterone biosynthesis in the rat brain
21. Corticosteroid synthesis in the central nervous system
22. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation
23. Activation of cardiac aldosterone production in rat myocardial infaction. Effect of angiotensin II receptor blockade and role in cardiac fibrosis
24. Cardiac aldosterone production in genetically hypertensive rats
25. Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy
26. A renally active substance from heart muscle and from blood
27. Similarity between a substance produced by the heart in vitro and the 18-monoacetyl derivative of d-aldosterone
28. The release of a renally active substance by perfused rat hearts
29. Isolation and characterization of a sodium retaining substance from pig heart muscle and its role in myocardial infarction
30. The production of monoclonal antibodies against aldosterone
31. A radioimmunoassay for plasma aldosterone by immunologic purification
32. The crystal structure and molecular conformation of aldosterone
33. The separation of renal activity from lung and from the venous effluent from perfused lungs
34. Cardiac hypertrophy: Mechanical, neural and endocrine dependence
35. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension
36. Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma
37. Further evaluation of saline infusion for the diagnosis of primary aldosteronism
38. High incidence of primary aldosteronism in 199 patients referred with hypertension
39. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients
40. Primary hyperaldosteronism in essential hypertensives: Prevalence, biochemical profile and molecular biology
41. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients
42. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators
43. What is the role of the central nervous system in mineralocorticoid hypertension?
44. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states
45. Role of adrenals on development of pressure-induced myocardial hypertrophy
46. Recognition of markers of response to potassium-canrenoate in essential hypertension
47. Effects of various adrenal inhibitors in low-renin essential hypertension
48. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats
49. Cardiac aldosterone production and ventricular remodelling
50. Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure
51. Steroidogenic enzyme gene expression in the human heart
52. Biological esterification of steroids
53. In vitro metabolism of adrenocortical hormones by mammary glands of lactating rats. A comparative study